Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships.

Moderator

Andrew J. Cutler, MD

Clinical Associate Professor of Psychiatry
SUNY Upstate Medical University
Syracuse, New York

Disclosures

Andrew J. Cutler, MD, has the following relevant financial relationships:
Consultant or advisor for: AbbVie; ACADIA Pharmaceuticals, Inc.; Alfasigma USA, Inc.; Alkermes, Inc.; Allergan; BioXcel Therapeutics; Corium International, Inc.; Intra-Cellular Therapies, Inc.; Ironshore; Janssen; Lundbeck; Neumora; Neurocrine Biosciences, Inc.; Noven Pharmaceuticals, Inc.; Otsuka Pharmaceutical Co., Ltd.; Pear Therapeutics; Relmada Therapeutics, Inc.; Sage Therapeutics; Sunovion Pharmaceuticals Inc.; Supernus Pharmaceuticals, Inc.; Takeda; Teva
Speaker or member of speakers bureau for: AbbVie; ACADIA Pharmaceuticals, Inc.; Alfasigma USA, Inc.; Alkermes, Inc.; Allergan; BioXcel Therapeutics; Corium International, Inc.; Intra-Cellular Therapies, Inc.; Ironshore; Janssen; Lundbeck; Neurocrine Biosciences, Inc.; Noven Pharmaceuticals, Inc.; Otsuka Pharmaceutical Co., Ltd.; Sunovion Pharmaceuticals Inc.; Supernus Pharmaceuticals, Inc.; Takeda; Teva

Panelists

Ann Childress, MD

President
Center for Psychiatry and Behavioral Medicine, Inc
Adjunct Faculty
UNLV School of Medicine
Touro University of Nevada College of Medicine
Las Vegas, Nevada

Disclosures

Ann Childress, MD, has the following relevant financial relationships:
Consultant or advisor for: Cingulate; Corium International, Inc.; KemPharm; Noven Pharmaceuticals, Inc.; Otsuka Pharmaceutical Co., Ltd.; Supernus Pharmaceuticals, Inc.
Speaker or member of speakers bureau for: Corium International, Inc.; Ironshore Pharmaceuticals, Inc.; Shire; Takeda; Tris Pharma, Inc.
Research funding from: Adlon Therapeutics; Akili Interactive Labs, Inc.; Allergan; Arbor Pharmaceuticals, Inc.; Emalex Biosciences; KemPharm; Otsuka Pharmaceutical Co., Ltd.; Purdue Pharma L.P.; Sunovion Pharmaceuticals Inc.; Supernus Pharmaceuticals, Inc.

Kristin Sohl, MD, FAAP

Professor of Clinical Child Health
University of Missouri
Executive Director
ECHO Autism
Columbia, Missouri

Disclosures

Kristin Sohl, MD, FAAP, has the following relevant financial relationships:
Consultant or advisor for: Quadrant Biosciences; Cognoa, Inc. (former)
Research funding from: Cognoa, Inc.

Editor

Clinton W. Wright, PharmD, BCPP

Medical Education Director, Medscape, LLC

Disclosures

Clinton W. Wright, PharmD, BCPP, has no relevant financial relationships.

Compliance Reviewer/Nurse Planner

Lisa Simani, APRN, MS, ACNP

Associate Director, Accreditation and Compliance, Medscape, LLC

Disclosures

Lisa Simani, APRN, MS, ACNP, has no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has no relevant financial relationships.

CME / CE

At the Leading Edge of ADHD Management: Highlights From a Recent Symposium

Authors: Andrew J. Cutler, MD; Ann Childress, MD; Kristin Sohl, MD, FAAP
CME / CE Released: 12/28/2022
Valid for credit through: 12/28/2023

Start Activity

Credits Available

Physicians - maximum of 0.75 AMA PRA Category 1 Credit(s)™

Nurses - 0.75 ANCC Contact Hour(s) (0 contact hours are in the area of pharmacology)

Pharmacists - 0.75 Knowledge-based ACPE (0.075 CEUs)

You Are Eligible For
- Letter of Completion

Target Audience and Goal Statement

This activity is intended for psychiatrists, pediatricians, primary care physicians, nurse practitioners, physician assistants, nurses, pharmacists, psychologists, and other healthcare professionals who provide care to patients with ADHD.

The goal of this activity is for learners to be better able to establish treatment targets for ADHD symptoms and select patients with ADHD who may benefit from multimodal treatment strategies.

Upon completion of this activity, participants will:

Have increased knowledge regarding the
- Establishment of treatment targets for patients with ADHD
Have greater competence related to
- Identifying patients who may benefit from multimodal treatment approaches
Demonstrate intent to act associated with
- Implementing shared decision-making with patients for consideration of incorporating nonpharmacologic interventions as part of a treatment program

Disclosures

Moderator

Andrew J. Cutler, MD

Clinical Associate Professor of Psychiatry
SUNY Upstate Medical University
Syracuse, New York

Disclosures

Andrew J. Cutler, MD, has the following relevant financial relationships:
Consultant or advisor for: AbbVie; ACADIA Pharmaceuticals, Inc.; Alfasigma USA, Inc.; Alkermes, Inc.; Allergan; BioXcel Therapeutics; Corium International, Inc.; Intra-Cellular Therapies, Inc.; Ironshore; Janssen; Lundbeck; Neumora; Neurocrine Biosciences, Inc.; Noven Pharmaceuticals, Inc.; Otsuka Pharmaceutical Co., Ltd.; Pear Therapeutics; Relmada Therapeutics, Inc.; Sage Therapeutics; Sunovion Pharmaceuticals Inc.; Supernus Pharmaceuticals, Inc.; Takeda; Teva
Speaker or member of speakers bureau for: AbbVie; ACADIA Pharmaceuticals, Inc.; Alfasigma USA, Inc.; Alkermes, Inc.; Allergan; BioXcel Therapeutics; Corium International, Inc.; Intra-Cellular Therapies, Inc.; Ironshore; Janssen; Lundbeck; Neurocrine Biosciences, Inc.; Noven Pharmaceuticals, Inc.; Otsuka Pharmaceutical Co., Ltd.; Sunovion Pharmaceuticals Inc.; Supernus Pharmaceuticals, Inc.; Takeda; Teva

Panelists

Ann Childress, MD

President
Center for Psychiatry and Behavioral Medicine, Inc
Adjunct Faculty
UNLV School of Medicine
Touro University of Nevada College of Medicine
Las Vegas, Nevada

Disclosures

Ann Childress, MD, has the following relevant financial relationships:
Consultant or advisor for: Cingulate; Corium International, Inc.; KemPharm; Noven Pharmaceuticals, Inc.; Otsuka Pharmaceutical Co., Ltd.; Supernus Pharmaceuticals, Inc.
Speaker or member of speakers bureau for: Corium International, Inc.; Ironshore Pharmaceuticals, Inc.; Shire; Takeda; Tris Pharma, Inc.
Research funding from: Adlon Therapeutics; Akili Interactive Labs, Inc.; Allergan; Arbor Pharmaceuticals, Inc.; Emalex Biosciences; KemPharm; Otsuka Pharmaceutical Co., Ltd.; Purdue Pharma L.P.; Sunovion Pharmaceuticals Inc.; Supernus Pharmaceuticals, Inc.

Kristin Sohl, MD, FAAP

Professor of Clinical Child Health
University of Missouri
Executive Director
ECHO Autism
Columbia, Missouri

Disclosures

Kristin Sohl, MD, FAAP, has the following relevant financial relationships:
Consultant or advisor for: Quadrant Biosciences; Cognoa, Inc. (former)
Research funding from: Cognoa, Inc.

Editor

Clinton W. Wright, PharmD, BCPP

Medical Education Director, Medscape, LLC

Disclosures

Clinton W. Wright, PharmD, BCPP, has no relevant financial relationships.

Compliance Reviewer/Nurse Planner

Lisa Simani, APRN, MS, ACNP

Associate Director, Accreditation and Compliance, Medscape, LLC

Disclosures

Lisa Simani, APRN, MS, ACNP, has no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has no relevant financial relationships.

Accreditation Statements

In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

For Physicians

Medscape, LLC designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Contact This Provider

For Nurses

Awarded 0.75 contact hour(s) of nursing continuing professional development for RNs and APNs; 0.00 contact hours are in the area of pharmacology.

Contact This Provider

For Pharmacists

Medscape designates this continuing education activity for 0.75 contact hour(s) (0.075 CEUs) (Universal Activity Number: JA0007105-0000-22-412-H01-P).

Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]

Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.

Follow these steps to earn CME/CE credit*:

Read about the target audience, learning objectives, and author disclosures.
Study the educational content online or print it out.
Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate, but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period, you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

At the Leading Edge of ADHD Management: How to Leverage Novel Technologies in Clinical Care

From Medscape Education Psychiatry & Mental Health

CME / CE

At the Leading Edge of ADHD Management: Highlights From a Recent Symposium

Authors: Andrew J. Cutler, MD; Ann Childress, MD; Kristin Sohl, MD, FAAPFaculty and Disclosures

CME / CE Released: 12/28/2022

Valid for credit through: 12/28/2023

processing....

Learning Feedback Questions

Please answer these questions to complement your learning experience.

Page 1 of 4

CME / CE Information Download Slides

Print
Like Tweet

Disclaimer

The educational activity presented above may involve simulated, case-based scenarios. The patients depicted in these scenarios are fictitious and no association with any actual patient, whether living or deceased, is intended or should be inferred. The material presented here does not necessarily reflect the views of Medscape, LLC, or any individuals or commercial entities that support companies that support educational programming on medscape.org. These materials may include discussion of therapeutic products that have not been approved by the US Food and Drug Administration, off-label uses of approved products, or data that were presented in abstract form. These data should be considered preliminary until published in a peer-reviewed journal. Readers should verify all information and data before treating patients or employing any therapies described in this or any educational activity. A qualified healthcare professional should be consulted before using any therapeutic product discussed herein.

Faculty and Disclosures

Moderator

Andrew J. Cutler, MD

Panelists

Ann Childress, MD

Kristin Sohl, MD, FAAP

Editor

Clinton W. Wright, PharmD, BCPP

Compliance Reviewer/Nurse Planner

Lisa Simani, APRN, MS, ACNP

Peer Reviewer

CME / CE

At the Leading Edge of ADHD Management: Highlights From a Recent Symposium

Credits Available

You Are Eligible For

Target Audience and Goal Statement

Disclosures

Moderator

Andrew J. Cutler, MD

Panelists

Ann Childress, MD

Kristin Sohl, MD, FAAP

Editor

Clinton W. Wright, PharmD, BCPP

Compliance Reviewer/Nurse Planner

Lisa Simani, APRN, MS, ACNP

Peer Reviewer

Accreditation Statements

For Physicians

For Nurses

For Pharmacists

Instructions for Participation and Credit

At the Leading Edge of ADHD Management: Highlights From a Recent Symposium

Learning Feedback Questions